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he C-type lectin dendritic cell (DC)–specific inter-
cellular adhesion molecule grabbing non-integrin
(DC-SIGN; CD209) facilitates binding and internal-
ization of several viruses, including HIV-1, on DCs, but the
 
underlying mechanism for being such an efficient phagocytic
pathogen-recognition receptor is poorly understood. By high
resolution electron microscopy, we demonstrate a direct
relation between DC-SIGN function as viral receptor and
its microlocalization on the plasma membrane. During
development of human monocyte-derived DCs, DC-SIGN
T
 
becomes organized in well-defined microdomains, with an
average diameter of 200 nm. Biochemical experiments
and confocal microscopy indicate that DC-SIGN micro-
domains reside within lipid rafts. Finally, we show that the
organization of DC-SIGN in microdomains on the plasma
 
membrane is important for binding and internalization
of virus particles, suggesting that these multimolecular
assemblies of DC-SIGN act as a docking site for pathogens
like HIV-1 to invade the host.
 
Introduction
 
In the past two years, several new genes have been identified
encoding leukocyte-specific carbohydrate binding proteins
that belong to the lectin-like receptors family (Kogelberg
and Feizi, 2001; Figdor et al., 2002). Many of these lectins
are members of the calcium-dependent C-type lectin family
and recognize their ligands through the structurally related
Ca
 
2
 

 
-dependent carbohydrate-recognition domains (C-type
CRDs; Drickamer, 1999). Many C-type lectins act as cell
adhesion receptors (Vestweber and Blanks, 1999), whereas
others are specialized in antigen recognition (Stahl and
Ezekowitz, 1998; Mahnke et al., 2000).
Dendritic cells (DCs) constitute a specific group of pro-
fessional antigen presenting leukocytes, constantly patrolling
the body for foreign intruders (Steinman 1991; Banchereau
and Steinman, 1998). DCs are equipped with a variety of
dynamically regulated pathogen-recognition receptors. Al-
though some of them are members of the toll-like receptor
(TLR) family, signaling molecules specialized in sensing
pathogens (Akira, 2003), others belong to the C-type lectin
family and mediate pathogen binding and uptake (Stahl and
Ezekowitz, 1998; Mahnke et al., 2000).
DC-specific intercellular adhesion molecule (ICAM) grab-
bing non-integrin (DC-SIGN; CD209) is a C-type lectin
specifically expressed by DCs and has a dual function. As an
adhesion receptor, DC-SIGN supports initial DC–T cell in-
teraction by binding to ICAM-3 (Geijtenbeek et al., 2000a),
and mediates tethering and rolling of DCs on the endo-
thelium by interacting with ICAM-2 (Geijtenbeek et
al., 2000c). As a pathogen-recognition receptor, DC-SIGN
binds HIV gp120 thus facilitating the transport of HIV
from mucosal sites to draining lymph nodes where infection
of T lymphocytes occurs (Geijtenbeek et al., 2000b). Recently,
DC-SIGN was also shown to bind other viruses like CMV
(Halary et al., 2002), Ebola (Alvarez et al., 2002), Dengue
(Tassaneetrithep et al., 2003), and hepatitis C (Lozach et al.,
2003; Pöhlmann et al., 2003), as well as microorganisms
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such as 
 
Leishmania
 
 (Colmenares et al., 2002), 
 
Candida albi-
cans
 
 (Cambi et al., 2003), 
 
Mycobacterium
 
 (Geijtenbeek et al.,
2003; Maeda et al., 2003; Tailleux et al., 2003), and 
 
Schisto-
soma
 
 (van Die et al., 2003).
Recent works have demonstrated that some microbial
pathogens exploit cholesterol-enriched lipid microdomains
as essential docking sites to enter host cells (Gatfield and
Pieters, 2000; Rosenberger et al., 2000; Lafont et al., 2002).
These microdomains, also known as lipid rafts, are localized
regions with elevated cholesterol and glycosphingolipid con-
tent that can be found on the plasma- and endosomal-mem-
brane of eukaryotic cells (London and Brown, 2000; Simons
and Toomre, 2000; Simons and Ehehalt, 2002). Some vi-
ruses, such as HIV-1, appear to target lipid raft micro-
domains during viral entry into cells, as well as during viral
assembly before budding from cells (Dimitrov, 1997; Mañes
et al., 2000). Other works suggest that cholesterol-depen-
dent membrane properties, rather than lipid rafts per se, are
responsible to promote efficient HIV-1 infection in T cells
(Percherancier et al., 2003).
DC-SIGN, like other C-type lectins, recognizes pathogens
by binding to carbohydrate moieties in a Ca
 
2
 

 
-dependent
manner, through a conserved CRD (Drickamer, 1999).
This CRD has a high specificity for complex mannose resi-
dues and is located at the distal end of the extracellular do-
main (ECD), which consists of several amino acid repeats
(Soilleux et al., 2000). Recently, purified truncated forms of
DC-SIGN containing either the complete ECD or only the
CRD were used to analyze the quaternary structure as well as
the affinity of DC-SIGN for its ligands. Biochemical experi-
ments indicated that in vitro ECDs aggregate to form tetra-
mers, thus enhancing DC-SIGN capacity to bind multiva-
lent ligands, such as pathogen sugar arrays (Mitchell et al.,
2001). Surface plasmon resonance experiments showed that
whereas the ECD readily binds hepatitis C virus glycopro-
tein E2, distant monomeric CRDs do not, unless closely
seeded (Lozach et al., 2003).
These findings suggest that the organization of DC-SIGN
molecules on the plasma membrane may be critical for
pathogen binding. This prompted us to investigate the cell
surface distribution pattern of DC-SIGN and its possible as-
sociation with lipid rafts. Using transmission EM (TEM) on
whole-mount samples of transfected cells and monocyte-
derived DCs, we have mapped the microlocalization of
DC-SIGN at high resolution. Subsequently, spatial-point
pattern analysis showed that DC-SIGN is organized in
well-defined microdomains. Moreover, biochemical experi-
ments and confocal microscopy analysis demonstrated that
DC-SIGN colocalizes with lipid rafts. Finally, we show that
these microdomains of DC-SIGN act as a docking site for
HIV-1 particles, facilitating entry of the virus into DCs.
 
Results
 
DC-SIGN is organized in microdomains 
on the cell surface
 
To study the correlation between functional state and cell
surface organization of DC-SIGN, we used K562 transfec-
tants stably expressing DC-SIGN. K-DC-SIGN expressed
high levels of DC-SIGN (Fig. 1 A) and bound strongly to
1-
 

 
m fluorescent beads coated with ICAM-3 or GP120 (Fig.
1 B). The binding of K-DC-SIGN to these ligands was spe-
cific, as shown by the inhibition exerted by anti–DC-SIGN
mAbs. Moreover, the lack of adhesion in presence of EGTA
confirmed that DC-SIGN bound to these ligands in a Ca
 
2
 

 
-
dependent manner, typical of C-type lectin-like receptors.
To determine the organization of DC-SIGN on the cell
membrane at high resolution, TEM was used on whole-
mount samples of K-DC-SIGN, after specific labeling with
anti–DC-SIGN mAb and 10-nm gold particles. It should be
noted that the specimens were not sectioned thus making the
whole cell surface available for gold labeling and subsequent
TEM analysis. This method has been successfully applied to
detect spatial distribution of other membrane proteins such
as the potassium channels Kv1.3 (Panyi et al., 2003) and the
IL-2 receptor 
 

 
-subunit (Vereb et al., 2000). As shown in
Fig. 1 C, DC-SIGN showed a clear distribution in well-
defined microdomains on K-DC-SIGN plasma membrane.
These microdomains had an average diameter of 200 nm and
appeared to be randomly localized on the cell surface. To ex-
clude that the gold labeling pattern observed could be due to
internalized DC-SIGN molecules; also, sections of these cell
samples were analyzed by TEM. The results demonstrated
that the gold particles were exclusively detected on the out-
side of the cell membrane (unpublished data), confirming the
presence of DC-SIGN in microdomains on the cell surface.
To show that the clustering of DC-SIGN is not an artifact
due to the procedure, we also analyzed by TEM other trans-
Figure 1. DC-SIGN is organized in microdomains on the cell 
surface of K-DC-SIGN. (A) The expression levels of DC-SIGN on 
untransfected K562 and on K-DC-SIGN were assessed by FACS® 
analysis. The open histogram represents the isotype control, and 
shaded histogram indicates the specific staining with anti–DC-SIGN 
(AZN-D1). (B) DC-SIGN expressed by K562 transfectants strongly 
binds to ICAM-3 and gp120. The adhesion was determined using 
1-m ligand-coated fluorescent beads. Specificity was determined 
by measuring binding in presence of AZN-D1. No blocking was 
observed in presence of isotype control (not depicted). Blocking 
exerted by EGTA indicates that DC-SIGN binds to the ligands in a 
Ca2-dependent manner. The average of five independent experi-
ments is shown (P  0.001). (C) K-DC-SIGN cells were specifically 
labeled with 10-nm gold particles, as described in Materials and 
methods. Cells were allowed to adhere onto poly-L-lysine–coated 
formvar film and photographed in an electron microscope. Gold 
particles were detected on the periphery on the thinner less electron 
dense parts of cells, where good contrast could be achieved. One 
representative picture is shown. Bar, 200 nm.
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membrane receptors transfected into K562, among which
the 
 

 
2-integrin LFA-1. Unlike DC-SIGN, LFA-1 molecules
showed a random distribution pattern (unpublished data). It
should be noted that the number of gold particles observed
per micrometer squared was generally comparable with that
observed for K-DC-SIGN, which should exclude difference
in distribution due to major difference in the expression lev-
els of the two receptors.
 
DC-SIGN predominantly resides in lipid rafts
 
To determine whether lipid rafts are important for DC-
SIGN function, K-DC-SIGN cells were treated with
methyl-
 

 
-cyclodextrin (MCD) to extract membrane choles-
terol, and its effect on DC-SIGN–mediated ligand binding
was tested by the fluorescent beads adhesion assay. As shown
in Fig. 2 A, MCD treatment partially inhibits binding to
gp120-coated beads, indicating that cholesterol extraction
partially affected DC-SIGN ligand binding capacity.
To further demonstrate the association of DC-SIGN with
lipid rafts, K-DC-SIGN cells were solubilized in Triton
X-100 on ice and fractionated by centrifugation on a sucrose
gradient at 4
 

 
C. With this procedure, lipid rafts, which can
be isolated as detergent-resistant membranes (DRM), were
recovered in low density fractions, whereas any other deter-
gent-soluble material was concentrated in the high density
fraction (Fig. 2 B). The GPI-anchored protein CD55 was
used as the raft marker and was found in raft fractions,
whereas the negative control (nonraft-associated protein),
CD46, was almost completely detectable in the nonraft frac-
tions. Similarly to CD55, a significant portion of DC-SIGN
was recovered in the low density fraction, indicating that
DC-SIGN is localized in DRM on the plasma membrane of
K-DC-SIGN cells.
To provide further evidence that DC-SIGN colocalizes
with lipid rafts, we examined the co-distribution of DC-
SIGN and the lipid raft marker ganglioside (GM1), on
K-DC-SIGN by antibody patching and confocal micros-
copy. As shown in Fig. 2 C, when capping was induced on
K-DC-SIGN cells, GM1 clearly colocalizes with DC-SIGN
and to the same extent as for CD55. However, some smaller
patches of DC-SIGN were also detectable outside the lipid
raft area, indicating that DC-SIGN might not permanently
reside in lipid rafts, as also observed in Fig. 2 B. As expected,
no colocalization of CD46 with GM1 was detected. Based
on these observations, we conclude that DC-SIGN resides
within a lipid raft environment on the plasma membrane of
K-DC-SIGN cells.
 
DC-SIGN distribution changes during DC development
 
During the differentiation of DCs from monocyte precursors,
the expression of DC-SIGN on the cell surface gradually in-
creases (Geijtenbeek et al., 2000a). However, as shown by
flow cytometry (Fig. 3 A), no significant increases in DC-
SIGN expression levels are seen between cells harvested after
3 d of culture (designated intermediate DCs) and immature
 
Figure 2.
 
DC-SIGN colocalizes with lipid rafts on K-DC-SIGN. 
 
(A) To investigate the effect of cholesterol depletion on DC-SIGN–
mediated adhesion, K-DC-SIGN cells were incubated in serum-free 
medium with or without 20 mM MCD for 30 min at 37
 

 
C. Subse-
quently, gp120-coated fluorescent beads (1-
 

 
m diam) were added 
and the mixture was incubated for an additional 30 min at 37
 

 
C. 
Binding was measured by flow cytometry. After MCD treatment, cell 
viability was assessed by trypan blue staining. The values represent 
the mean of three independent experiments 
 

 
SD. (B) K-DC-SIGN 
were solubilized with 1% Triton X-100, subjected to sucrose gradient 
centrifugation and analyzed by Western blotting for the indicated 
molecules. The numbers indicate the gradient fractions. Fractions 9 
and 10 are low density fractions containing DRM and are referred to 
as raft fractions. (C) Confocal microscopy analysis of copatching of 
DC-SIGN and GM1. K-DC-SIGN cells were stained at 4
 

 
C with 10 
 

 
g/ml anti–DC-SIGN (or anti-CD55 or anti-CD46) and 10 
 

 
g/ml 
FITC-CTxB. Co-patching was induced by adding secondary Ab 
(Materials and methods), and, after fixation in PFA, cells were analyzed 
by confocal microscopy. Merged images are shown in the right panel. 
Results are representatives of multiple cells in three independent 
experiments. Bar, 5 
 

 
m.
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DCs. Maximum DC-SIGN–mediated adhesion to ICAM-3
as well as GP120 was observed on immature DCs, although
already on intermediate DC DC-SIGN was capable of com-
pletely mediating the binding to ICAM-3 (Fig. 3 B, top),
which on monocytes is LFA-1 dependent (unpublished data).
Comparably, while on monocytes, binding to gp120 is medi-
ated by CD4 (Kedzierska and Crowe, 2002; Kohler et al.,
2003), on intermediate DCs, as well as on immature DCs,
DC-SIGN is almost entirely responsible for binding to gp120
(Fig. 3 B, bottom). To examine DC-SIGN cell surface distri-
bution, both intermediate and immature DCs were allowed to
adhere to fibronectin, and DC-SIGN molecules were labeled
with gold particles. Subsequently, the distribution on the
plasma membrane was analyzed by TEM (Fig. 3 C). Given
the high capacity of DCs to widely spread on the used sub-
strates, very large membrane areas (often up to 60–70% of the
whole visible plasma membrane) were available for gold parti-
cles analysis, ensuring that the areas used for quantitation were
truly representative (Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200306112/DC1). Surprisingly, we
found that the distribution of DC-SIGN changes dramatically
during DC development. Although on intermediate DCs, the
 
gold particles are evenly distributed over the cell surface, on
immature DCs, there is a clear organization of DC-SIGN in
spatially well-defined microdomains. To exclude the possible
influence of the fibronectin substrate on DC-SIGN distribu-
tion, TEM analysis was also performed on DCs that were gold
labeled in suspension and mounted onto poly-
 
L
 
-lysine. No
differences were seen between cells stretched on fibronectin or
cells adhering to poly-
 
L
 
-lysine (unpublished data). Moreover,
thin sections of resin-embedded immature DCs were gold la-
beled and analyzed by TEM. Clusters of DC-SIGN molecules
could be observed exclusively at the plasma membrane (un-
published data). We also analyzed by TEM the cell surface dis-
tribution of other transmembrane receptors expressed on
DCs, including LFA-1. Unlike DC-SIGN, LFA-1 did not
show any changes in cell surface distribution pattern on inter-
mediate and immature DCs (unpublished data).
To quantitatively describe the DC-SIGN distribution pat-
tern, the nearest neighbor distance values among the gold
particles were calculated applying a spatial-point pattern
analysis. A quantitative comparison of DC-SIGN clustering
among intermediate DCs, immature DCs, and K-DC-SIGN
is shown in Fig. 4 A. On immature DCs, as well as on
Figure 3. DC-SIGN cell surface distribution during monocyte-
derived DC development. DC-SIGN binding activity was monitored 
during development of monocyte-derived DCs. As shown in the box, 
intermediate DCs indicate cells harvested after 3 d of monocytes 
differentiation. (A) The expression levels of DC-SIGN on monocytes, 
intermediate and immature DCs were assessed by FACS® analysis. 
The dotted line histogram represents the isotype control, and the thick 
line histogram indicates the specific staining with anti–DC-SIGN 
(AZN-D1). Mean fluorescence intensity is indicated. One represen-
tative donor is shown. (B) The adhesion to ICAM-3 and gp120 was 
determined using 1 m ligand-coated fluorescent beads. Specificity 
was determined by measuring binding in presence of AZN-D1. No 
blocking was observed in presence of isotype control (not depicted). 
One representative experiments out of three is shown. (C) Intermediate and immature DCs were let adhere onto fibronectin-coated formvar 
film, specifically labeled for DC-SIGN with 10-nm gold particles (Materials and methods), and analyzed by TEM. Results are representatives 
of multiple cells in several independent experiments. Bar, 200 nm.
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K-DC-SIGN, almost 70 and 80% of the gold particles reside
within a 50-nm distance from its nearest neighbor, respec-
tively. In contrast, on intermediate DCs, only 30% of the
nearest neighbor distance values are found in the same cate-
gory, and the majority of interparticle distances rather fall
within the 50–150 nm range. It has to be noted that the in-
termediate and the immature DCs compared by spatial-point
pattern analysis had a similar amount of gold particles per
micrometer squared, confirming the comparable expression
levels of DC-SIGN on the two cell types.
Similarly to what was observed for K-DC-SIGN, on imma-
ture DCs, these microdomains were also found to have an av-
 
erage diameter of 
 

 
200 nm and were separated from each
other by an average distance of 400 nm. Spatial analysis of the
microdomains distribution over the cell surface did not reveal
any preferential localization in specific surface areas of the ob-
served cells. These data were also confirmed by using high res-
olution near-field fluorescence imaging (unpublished data).
The relative partitioning of gold particles in clusters of
various sizes (i.e., number of particles/cluster) was also quan-
tified. A value of 50 nm was set to define the involvement of
a gold particle in a cluster. Fig. 4 D shows that on interme-
diate DCs up to 80% of gold particles occur as single fea-
tures. In contrast, on immature DCs (Fig. 4 C), as well as on
Figure 4. Quantitative analysis of the distribution of 
gold particles labeling DC-SIGN. The digital images of 
electron micrographs were processed by a custom-written 
software based on Labview. Gold labels were counted, and 
coordinates were assigned to each feature. Subsequently, 
interparticles distances were calculated using a nearest 
neighbor distance algorithm. Nearest neighbor distance 
values were calculated for each image, and the data of 
several independent experiments were pooled. Subse-
quently, the nearest neighbor distances were divided into 
three classes 0–50 nm (gray bar), 50–150 nm (black bar), 
and 	150 nm (white bar), and the percentage of nearest 
neighbor distance values falling into each class was plotted 
(A). The partitioning of gold labels in clusters of various 
size (i.e.: number of particles/cluster) was also quantified. 
Clusters were defined when gold particles were 50 nm 
apart from a neighboring particle. The percentage of gold 
particles involved in the formation of a certain cluster size 
was calculated for (B) K-DC-SIGN, (C) immature DC, and 
(D) intermediate DC. The insets are three representative 
processed digital images, where each type of cluster is 
shown in a different color. For K-DC-SIGN, one represen-
tative experiment out of two is shown; for immature DC, 
one representative experiment out of six is shown; and for 
intermediate DCs, one representative experiment out of 
three is shown.
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K-DC-SIGN (Fig. 4 B), DC-SIGN shows a much broader
distribution of cluster sizes, with an average of 10–20 gold
particles per cluster on immature DCs.
 
DC-SIGN resides in lipid rafts on DCs
 
Because, on K-DC-SIGN, we found a clear association of
DC-SIGN with lipid rafts, we investigated whether DC-
SIGN also colocalized with lipid rafts on immature DCs.
Extraction of cholesterol by MCD resulted in a significant
block in binding of both ICAM-3– and gp120-coated beads
(Fig. 5 A). In contrast, DC-SIGN–mediated binding on in-
termediate DCs was not affected by cholesterol depletion
(unpublished data).
To further demonstrate an interaction of DC-SIGN with
lipid rafts on immature DCs, we investigated the co-distri-
bution of DC-SIGN and GM1 by confocal microscopy. Fig.
5 B shows that, when capping was induced, DC-SIGN
clearly colocalized with GM1, almost to the same extent as
the raft marker CD55. However, similarly to what was ob-
served on K-DC-SIGN, small patches of DC-SIGN were
also found not colocalizing with GM1. To further prove the
colocalization of GM1 with DC-SIGN, we performed dou-
ble gold labeling for DC-SIGN and GM1 on immature
DCs, and analyzed the samples by TEM. As shown in Fig. 5
C, GM1 (10 nm gold) was found within DC-SIGN micro-
domains (5 nm gold). Consistent with observations by con-
focal microscopy, some microdomains of DC-SIGN that
lacked GM1 were also detected. Together, these results
demonstrate that on immature DC DC-SIGN resides in mi-
crodomains that to a significant extent are associated with a
lipid rafts environment.
 
DC-SIGN in microdomains facilitates binding 
to virus-sized particles
 
We showed that fluorescent beads coated with DC-SIGN–
specific ligands were bound by immature as well as interme-
diate DCs, apparently independently of DC-SIGN organi-
zation on the cell membrane (Fig. 3, A and B).
Figure 5. DC-SIGN resides in lipid rafts on immature DCs. (A) DC-SIGN–mediated adhesion to ligand-coated fluorescent beads (1-m diam) 
on immature DCs was measured after cholesterol depletion by 20 mM MCD. The assay was performed as described in Fig. 2 A. Data shown 
are means  SD of one representative experiment performed in triplicate out of three. One representative experiment out of three is shown. 
(B) Confocal microscopy analysis of copatching of DC-SIGN and GM1 on immature DCs. Staining was performed as described in Fig. 2 C. 
Cells were analyzed by confocal microscopy. Merged images are shown in the right panel. Results are representative of multiple cells in two 
independent experiments. Bar, 5 m. (C) Whole-mount samples of immature DCs were double labeled for DC-SIGN (5 nm gold) and the raft 
marker GM1 (10 nm gold) and analyzed by TEM. Thin white arrows indicate GM1 colocalizing in DC-SIGN microdomains. Thick white 
arrows indicate DC-SIGN microdomains with no GM1. Black arrow indicates GM1 alone. Results are representatives of multiple cells in two 
independent experiments. Bar, 50 nm.
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However, because DC-SIGN on immature DCs is an ex-
quisite virus receptor and the fluorescent beads are at least
one order of magnitude larger than viral particles, we inves-
tigated whether clustering of DC-SIGN into higher order
assemblies might be needed to stabilize interactions with vi-
rus-sized particles. To detect possible differences in “avidity”
for multimeric ligands between scattered and clustered DC-
SIGN molecules, and to mimic virus binding to DC-SIGN,
we used fluorescent virus-sized microbeads of 40-nm diam,
coated with gp120, which are now referred to as virus-sized
particles. The extremely broad fluorescence emission peak of
these microbeads currently precludes accurate quantification
by flow cytometry, therefore binding of DCs to these virus-
sized particles was visualized by confocal microscopy.
When comparing the capacity of intermediate and imma-
ture DCs to bind these virus-sized particles (Fig. 6), a very
high binding was observed on immature DCs. Many virus-
sized particles were bound to the plasma membrane and a
significant amount was phagocytosed (Fig. 6, D and E). In
contrast, intermediate DCs (Fig. 6, A and B) hardly bound
any microbeads, comparable to background levels or when
DCs were pretreated with the carbohydrate mannan to
block DC-SIGN (Fig. 6, C and F). Similar results were ob-
tained when microbeads coated with ICAM-3 were used
(unpublished data). Moreover, DC-SIGN on intermediate
as well as on immature DCs was found to be equally capable
of binding to soluble recombinant gp120 (Fig. 6 G), sug-
gesting that the intrinsic binding capacity of DC-SIGN
molecule on the two different DC types is comparable. Sim-
ilar results were obtained when soluble ICAM-3-Fc chime-
ras were used (unpublished data). All these observations sup-
port our hypothesis that DC-SIGN molecules acquire a
higher avidity for multimeric ligands when organized in
multimolecular assemblies.
 
DC-SIGN microdomains enhances HIV-1 infection
 
Having established that DC-SIGN microdomains bind
virus-sized particles more efficiently in comparison to
randomly distributed receptor molecules, we investigated
whether the uptake of real virus was also enhanced by a clus-
Figure 6. DC-SIGN microdomains on 
immature DCs bind virus-sized particles. 
Green fluorescent microbeads (40-nm 
diam) were coated with gp120 and added 
to the cells in a ratio of 20 beads/cell. The 
cells were incubated for 30 min at 37C, 
washed, and fixed in PFA. DC-SIGN was 
stained with AZN-D1 and Alexa 647–
conjugated goat anti–mouse Ab (red). 
Subsequently, the cells were mounted 
onto poly-L-lysine–coated glass coverslips 
and analyzed by confocal microscopy. 
The overview of binding to gp120 micro-
beads of (A) intermediate DCs and (D) 
immature DCs is shown. Two represen-
tative cells of (B) intermediate and (E) 
immature DCs are shown. Specific block 
with 100 g/ml mannan was also per-
formed by preincubating the cells at RT 
for 10 min before adding the microbeads 
(C and F); bars, 5 m. Similar results 
were obtained with ICAM-3–coated 
microbeads (not depicted). (G) Binding 
of K-DC-SIGN, intermediate DCs, and 
immature DCs to soluble gp120 was also 
performed: 50,000 cells were incubated 
with 50 mM biotinylated gp120 for 
30 min on ice, in presence or absence of 20 g/ml anti–DC-SIGN blocking mAb (AZN-D1). 
A subsequent incubation with Alexa 488–conjugated streptavidin for 30 min on ice 
followed, and gp120 molecules bound to the cells were detected by flow cytometry. 
The values represent the mean of three independent experiments SD.
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tered distribution of DC-SIGN, using p24 ELISA. There-
fore, intermediate and immature DCs were pulsed for 2 h
with HIV-1 (M-tropic HIV-1Ba-L strain), washed, and cul-
tured in the presence of activated peripheral blood mononu-
clear cells (PBMC). As shown in Fig. 7, virus replication was
significantly higher when PBMC were cocultured with ei-
ther intermediate or immature DCs with respect to PBMC
alone challenged with the same amount of infectious virus.
However, infection of PBMC cultured with virus-pulsed
immature DCs was much higher than the infection exhib-
ited by PBMC cultured with intermediate DCs. In addition,
the infection of PBMC with immature DCs was signifi-
cantly blocked by anti–DC-SIGN mAbs that were added to
DCs before incubation with HIV-1. In contrast, DC-SIGN
contribution to PBMC infection was clearly much lower
when intermediate DCs were used. The incomplete block-
ing observed in the presence of anti–DC-SIGN Abs suggests
the involvement of other HIV receptors also expressed on
DCs (Turville et al., 2002). The comparable expression lev-
els of DC-SIGN, as shown in Fig. 3 A, as well as several co-
stimulatory molecules (such as CD40 and CD80) on inter-
mediate and immature DCs suggest that these two DC types
have similar antigen presentation capacity (unpublished
data). Altogether, our data demonstrate that DC-SIGN or-
ganized in microdomains rather than randomly distributed
is more efficient in mediating binding and uptake of virus-
sized microbeads as well as real HIV-1 particles.
 
Discussion
 
DC-SIGN is a DC-specific C-type lectin that acts both as
adhesion molecule and as pathogen-recognition receptor.
Here, we demonstrate that DC-SIGN can form micro-
domains on the plasma membrane, and that there is a direct
correlation between the distribution of DC-SIGN in micro-
domains and its capacity to bind and internalize virus-sized
ligand-coated particles. Moreover, to the best of our knowl-
edge, this is the first report describing a C-type lectin in a
lipid raft environment on DCs that forms highly organized
well-defined (200 nm) multiprotein assemblies on the sur-
face of a cell.
To establish the association of proteins with lipid rafts is
complicated and often controversial, which underscores the
complexity of cell membranes. These lipid domains differ in
their composition, physical properties, and biological func-
tions (Schuck et al., 2003). Moreover, lipid raft composi-
tions differ between cell types. Finally, the dynamics of the
chemical membrane composition adds a further level of
complexity. Therefore, the association of proteins with lipid
rafts can only be analyzed using different techniques simul-
taneously. Our observation that DC-SIGN resides within
lipid rafts is based on several well-established raft analysis
techniques. First, we showed by biochemical experiments
the partitioning of DC-SIGN in DRM. Second, co-patch-
ing of DC-SIGN with the lipid raft marker GM1 was
observed by confocal microscopy. Third, this association
between DC-SIGN and GM1 was confirmed by TEM.
Fourth, cholesterol extraction by MCD inhibited DC-
SIGN–mediated binding. Surprisingly, on immature DCs,
the same MCD treatment did not have any effect on the or-
ganization of DC-SIGN microdomains, as observed by
TEM (unpublished data). This may be explained by the fact
that the remaining cholesterol may be sufficient to keep such
domains intact (Schuck et al., 2003). Moreover, besides
cholesterol, also glycosphingolipids, another lipid raft com-
ponent, which is not depleted by MCD treatment, may in
part maintain the integrity of DC-SIGN microdomains.
The fact that cholesterol extraction by MCD partially affects
DC-SIGN–mediated binding could be explained by consid-
ering the pleiotropic effects that MCD can have on cell
functions, besides disrupting lipid rafts integrity (Brown and
London 2000; Edidin 2001; Schuck et al., 2003). There-
fore, MCD treatment can only be a preliminary indicator
for a possible association of a protein with a lipid rafts envi-
ronment. Also, it should be added that, unlike for GPI-
anchored proteins, very little is known about how trans-
membrane proteins are recruited into lipid rafts, how stable
these interactions are and what exactly the role of cholesterol
is. Further experiments are needed to better identify the mo-
lecular determinants that control the association of trans-
membrane proteins with lipid rafts.
In vitro experiments with isolated recombinant C-type lec-
tins suggested that these can oligomerize providing multiple
surfaces to bind (multivalent) ligands (Drickamer, 1999).
DC-SIGN has been shown to form tetramers stabilized by an
 

 
-helical stalk (Mitchell et al., 2001), and purified truncated
forms of DC-SIGN containing the complete ECD were also
shown to be able to bind ligands by surface plasmon reso-
nance (Lozach et al., 2003). In these works, the affinity of
isolated CRDs or complete ECDs of DC-SIGN for the ligand
was measured and compared with the affinity of the
membrane-bound form. Although no interactions with the
ligand could be found using isolated CRDs, significant bind-
ing was detected if single CRDs were closely seeded (
 
K
 
d
 
 
 


 
 48
nM) or if CRDs were part of a complete oligomeric-soluble
ECD of DC-SIGN (
 
K
 
d
 
 
 


 
 30 nM). The highest affinity was
seen with membrane-bound DC-SIGN expressed on the sur-
face of transfected cells (
 
K
 
d
 
 
 


 
 3 nM), suggesting that the nat-
Figure 7. Clustered DC-SIGN molecules efficiently bind HIV-1 
particles and infect PBMC. DC-SIGN on immature DCs enhances 
HIV-1 infection as measured in a DC-PBMC coculture. Either inter-
mediate or immature DCs (1.5  106) were preincubated for 20 min 
at RT with or without blocking mAb against 20 g/ml DC-SIGN 
(AZN-D1 and AZN-D2). Preincubated intermediate or immature DCs 
were pulsed for 2 h with HIV-1 (M-tropic HIV-1Ba-L strain), and 
unbound virus particles and mAb were washed away. Subsequently, 
DCs were cocultured with activated PBMC (1.5  106) for 7 d. 
Coculture supernatants were collected, and p24 antigen levels were 
measured by ELISA. Black histogram represents PBMC infected in the 
absence of DCs. One representative experiment out of two is shown.
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ural plasma membrane environment strongly influences the
function of this receptor. To some extent, this mirrors our
observations: DC-SIGN on the cell surface of intermediate
DCs is randomly distributed and hardly binds virus-sized
particles, whereas on immature DCs, the protein is organized
in well-defined microdomains, which allows binding of 40-
nm virus-sized particles (Fig. 6, A–F). In apparent contrast,
we showed that on intermediate DCs, randomly distributed
DC-SIGN was able to bind 1-
 

 
m beads, coated with ICAM-3
or gp120 (Fig. 3 B). This apparent discrepancy between
40-nm virus-sized particles and 1-
 

 
m beads can be explained
by the fact that beads of 1-
 

 
m diam have 
 

 
600-fold larger
interaction surface saturated with numerous ligand molecules
that can engage simultaneous interactions with several indi-
vidual DC-SIGN molecules. These multiple interactions
may signal into the cell and lead to a rapid recruitment of
new DC-SIGN molecules, thus strengthening the binding.
In contrast, when virus-sized particles are used, the contact
surface and therefore, the number of ligand molecules is
much smaller. Consequently, only interactions with DC-
SIGN molecules in highly organized multiprotein assemblies
can result in stable binding of virus-sized particles (Fig. 8).
When a computer-aided simulation was performed to predict
the capacity of round objects of different sizes to establish in-
teractions with either random or clustered DC-SIGN mole-
cules, we found that objects with a diameter in the range of
virus sizes (40–200-nm diam) preferentially bind to clusters
of DC-SIGN having the same size (unpublished data). In
agreement with this model, no significant differences were
detected in binding of intermediate and immature DCs to
soluble gp120 or to ICAM-3-Fc chimeras, indicating that the
capacity of each single DC-SIGN molecule to recognize and
bind the ligand is comparable on both DC types (Fig. 6 G).
The biological relevance of this clustering phenomenon is
shown by the fact that immature DCs compared with inter-
mediate DCs showed an enhanced DC-SIGN–mediated
binding and internalization of virus particles, and subse-
quent infection of PBMC in trans (Fig. 7). Therefore, we
propose that engagement of viruses with DC-SIGN occurs
much more productively when this receptor is organized in
microdomains and resides in a lipid raft or cholesterol-
enriched environment.
It remains to be established what controls DC-SIGN ran-
dom distribution on intermediate DCs and what mecha-
nism is responsible for the change into a clustered organi-
zation on immature DCs. We cannot exclude that, on
intermediate DCs, DC-SIGN may interact with an un-
known membrane associated protein that prevents the for-
mation of such microdomains. Alternatively, cytoskeletal
constraints may differ between these cells, and this issue is
currently under investigation. Preliminary observations sug-
gest that releasing DC-SIGN molecules from the cortical ac-
tin cytoskeleton by cytochalasin D treatment results in an
enhanced ligand binding, particularly on intermediate DCs
(unpublished data). Further experiments are needed to ob-
tain insight into the formation of DC-SIGN multiprotein
assemblies on DCs.
DC-SIGN belongs to the C-type lectin family that, to-
gether with the TLR family, forms the first barrier against
invading pathogens. This occurs through recognition of
pathogen-associated molecular patterns displayed at the
cell surface of microorganisms. Although TLRs have been
shown to induce differential gene expression upon recogni-
tion of distinct pathogen structural components (Akira,
2003), for the C-type lectins, and particularly for DC-
SIGN, no direct signaling pathways has been demonstrated
so far. Therefore, it will be interesting to investigate the in-
teractions that might occur between these two families of
pathogen-recognition receptors.
In conclusion, our findings emphasize the importance of
relating the function with the cell surface organization of
DC-SIGN. Clustered distribution is essential to enhance the
interaction as well as the internalization efficiency of DC-
SIGN–pathogen complexes. In addition, our data highlight
the importance of the plasma membrane as a specialized
microenvironment, where finely orchestrated interactions
among proteins, carbohydrates, and lipids take place. These
complex interactions mediate many fundamental processes
that occur at the contact site between cells (cell–cell or cell–
pathogen), such as assembly of signaling platforms and for-
mation of entry portals for invasive pathogens.
Insight in the cell surface organization of pathogen
scavenger receptors like DC-SIGN will contribute to the
development of novel strategies that specifically inhibit
interactions with life-threatening pathogens like HIV-1 or
 
Mycobacterium.
 
Materials and methods
 
Antibodies and reagents
 
For labeling as well as blocking of DC-SIGN, the mAb AZN-D1 was used
(Geijtenbeek et al., 2000a). For detection of CD46 and CD55 the Abs E4.3
(BD Biosciences) and 143–30 (CLB) were used, respectively. Alexa 647–
conjugated goat anti–mouse IgG was purchased from Molecular Probes.
FITC-conjugated cholera toxin B subunit (FITC-CTxB), Triton X-100, and
MCD were purchased from Sigma-Aldrich. Goat anti-CTxB antibody was
purchased from Calbiochem.
 
Cells
 
Monocytes were obtained from buffy coats of healthy individuals and were
purified using Ficoll density centrifugation. Immature DCs were obtained
as reported elsewhere (Geijtenbeek et al., 2000a). In brief, DCs were cul-
Figure 8. DC-SIGN microdomains enhances binding of virus-sized 
particles with respect to isolated DC-SIGN molecules. Beads of 
1-m diam are saturated with numerous coated ligand molecules 
that can engage simultaneous interactions with several individual 
DC-SIGN molecules. These multiple interactions may strengthen the 
binding both with random and clustered DC-SIGN. In contrast, when 
virus-sized particles are used, the contact surface and therefore, the 
number of ligand molecules is much smaller. Consequently, only 
interactions with DC-SIGN molecules in highly organized multipro-
tein assemblies may result in stable binding of virus particles.
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tured from monocytes in presence of IL-4 and GM-CSF (500 and 800
U/ml, respectively) for 3 d to obtain intermediate DCs and for 6 d to obtain
immature DCs. Stable K562 transfectants expressing DC-SIGN (K-DC-
SIGN) were generated as published previously (Geijtenbeek et al., 2000a).
 
Adhesion assays
 
Carboxylate-modified TransFluorSpheres (488/645 nm, 1-
 

 
m diam; Mo-
lecular Probes) were coated with ICAM-3-Fc or GP120, and the fluores-
cent beads adhesion assay was performed as described previously (Geij-
tenbeek et al., 1999). When the lipid raft-disrupting agent MCD was used,
the cells were resuspended in serum-free medium containing the appropri-
ate concentration of MCD and preincubated for 30 min at 37
 

 
C. When
necessary, 50,000 cells were incubated with 20 g/ml blocking mAb for
10 min at RT. The ligand-coated fluorescent beads (20 beads/cell) were
added and the suspension was incubated for 30 min at 37C. Adhesion
was determined by measuring the percentage of cells, which have bound
fluorescent beads, by flow cytometry using the FACSCalibur™ (Becton
Dickinson). Streptavidin-modified TransFluorSpheres (505/515 nm, 40-nm
diam; Molecular Probes) were coated with ICAM-3-Fc or GP120 as de-
scribed previously for 1-m beads (Geijtenbeek et al., 1999) and were
added to DCs in a ratio of 20 beads/cell. Bound beads were detected by
confocal microscopy analysis of the cells.
When binding to soluble GP120 was performed, 50 mM biotinylated
GP120 was added to the cells (105) for 30 min on ice, in presence or ab-
sence of 20 g/ml anti–DC-SIGN blocking Ab (AZN-D1). After the incuba-
tion, cells were extensively washed and incubated with Alexa 488–con-
jugated streptavidin for 30 min on ice. Subsequently, bound GP120
molecules were detected by flow cytometry.
Labeling procedures
For flow cytometry analysis, cells were incubated (30 min; 4C) in PBA
(PBS, containing 0.5% BSA and 0.01% sodium azide), with different mAb
(5 g/ml), followed by incubation with FITC-labeled goat anti–mouse IgG
antibody (GAM-FITC; Zymed Laboratories; 1:50 dilution in PBA) for 30
min at 4C. The relative fluorescence intensity was measured on a FACS-
Calibur™. Isotype–specific controls were included. For TEM, K-DC-SIGN
were fixed onto poly-L-lysine–coated formvar, whereas DCs were allowed
to spread on glass coverslips covered by a thin layer of fibronectin-coated
formvar for 1 h at 37C and immediately fixed with 1% PFA for 15 min. Af-
ter two washing steps with PBS and a subsequent incubation (60 min at
RT) with I-buffer (PBS, 0.1% glycine, 1% BSA, and 0.25% gelatin) to re-
duce a specific background, the specimens were incubated for 30 min
with the primary antibodies in I-buffer on ice, rinsed in PBS, and fixed in
1% PFA and 0.1% glutaraldehyde for 15 min. After two washing steps with
PBS and a block in I-buffer, the samples were incubated with rabbit anti–
mouse IgG (to detect mAb) for 30 min on ice. A final incubation with 10-
nm-diam gold-labeled Protein A (to detect polyclonal antibodies) was per-
formed, followed by final fixation in 1% glutaraldehyde in phosphate
buffer for 20 min at RT. When double labeling was performed, the cells
were treated as described above, except that anti–DC-SIGN (AZN-D1),
and biotinylated-CTxB were added simultaneously; and finally, goat anti–
mouse-conjugated 5-nm gold and streptavidin-conjugated 10-nm gold
were used to label DC-SIGN and GM1, respectively. Isotype-specific con-
trols were always included. The 10-nm-diam gold-labeled protein A was a
gift of M. Wijers and H. Croes (Nijmegen Center for Molecular Life Sci-
ences). The goat anti–mouse-conjugated 5-nm gold and streptavidin-con-
jugated 10-nm gold were purchased from Aurion.
EM and analysis of the distribution patterns of gold particles
After gold labeling and fixation, the specimens were dehydrated by se-
quential passages through 30, 50, 70, 90%, and absolute ethanol. Next,
the ethanol was substituted by liquid CO2, and the samples were critical
point dried. The formvar films were transferred from the glass onto copper
grids, and the specimens were observed in a transmission electron micro-
scope (model 1010; JEOL), operating at 60–80 kV. Gold particles were de-
tected on the periphery and thinner parts of cells, where a good contrast
could be achieved. In case of DCs, which widely spread (Fig. S1), the
membrane area available for analysis represented up to 60–70% of the
whole labeled plasma membrane. For each cell at least four to six areas
were analyzed at random. The digital images of electron micrographs were
processed by custom-written software based on Labview (National Instru-
ments). The distribution pattern of DC-SIGN (i.e., the degree of clustering)
was analyzed by counting the number of gold particles found on the
plasma membrane in a semi-automatic fashion. Subsequently, coordinates
were assigned to the observed beads and interparticles distance statistics
were obtained using a nearest neighbor distance algorithm. Clusters were
defined when gold particles were less than a set distance apart from a
neighboring particle.
Confocal microscopy
Cells were stained at 4C with 10 g/ml anti–DC-SIGN antibody (AZN-
D1), anti-CD55 antibody, anti-CD46 antibody, and 10 g/ml FITC-CTxB.
Isotype-specific controls were always included. Secondary staining for
DC-SIGN, CD55, and CD46 was with Alexa 647–conjugated goat anti–
mouse IgG, and for FITC-CTxB with goat anti-CTxB. Patching was induced
by incubation at 12C for 1 h, followed by fixation with 1% PFA. Cells
were mounted onto poly-L-lysine–coated glass coverslips. Signals were
collected sequentially to avoid bleed through.
Detergent extraction and flotation assay
For detergent resistant membrane isolation, K-DC-SIGN cells (10  106)
were lysed on ice in 0.5 ml of lysis buffer (50 mM Tris, pH 7.4, 150 mM
NaCl, 5 mM EDTA, and 1% Triton X-100, plus a cocktail of protease inhibi-
tors: 1 mM PMSF, 10 g/ml aprotinin, and 10 g/ml leupeptin). After 30 min
of incubation, the lysate was made 40% with respect to sucrose. Next, the
lysate-sucrose mixture was overlaid with 2 ml of 30% sucrose in lysis buffer
and finally with 1 ml of 4% sucrose in lysis buffer. The mixture was centri-
fuged at 200,000 g for 14–16 h in an SW60Ti rotor (Beckman Coulter). The
gradient was fractionated in 0.5-ml fractions from the bottom of the tube.
Immunoblot analysis
Proteins from the sucrose fractions were separated by SDS-PAGE and trans-
ferred to PROTRAN nitrocellulose transfer membranes (Schleicher &
Schuell). Membranes were blocked for 1 h at RT using 2% nonfat dried milk
(Campina) and 1% BSA (Calbiochem) in 0.1% PBS/Tween 20. Blots were
subsequently incubated with specific antibodies (polyclonal anti-CD55 and
CD46 from Santa Cruz Biotechnology, Inc., and a polyclonal anti–DC-
SIGN antibody [CSRD] that was raised in our laboratory), followed by the
appropriate HRP-conjugated secondary antibodies (DakoCytomation). Fi-
nally, proteins were detected using ECL (Amersham Biosciences).
HIV-1 infection of DCs
Infection of intermediate and immature DCs with the M-tropic strain HIV-
1Ba-L was performed as described previously (Geijtenbeek et al., 2000b).
In brief, intermediate and immature DCs (1.5  106) were incubated with
mAb against 20 g/ml DC-SIGN (AZN-D1 and 20 g/ml AZN-D2 for 20
min at RT. Subsequently, cells were incubated with the M-tropic strain
HIV-1Ba-L for 2 h with a multiplicity of infection of 0.004. After incuba-
tion, cells were washed and cocultured with activated PBMC in the pres-
ence of 5 U/ml human recombinant IL-2 (Roche Diagnostics). PBMC were
activated by culturing them before infection for 3 d in the presence of 2
g/ml of phyto-HA (Sigma-Aldrich). After 7 d, culture supernatants were
collected, and p24 antigen levels were determined by a p24 antigen ELISA
(AMPAKTM; DakoCytomation).
Online supplemental material
Fig. S1 is an overview of DC whole-mount samples by TEM. To determine
the organization of DC-SIGN on the cell membrane at high resolution, TEM
was used on whole-mount samples of intermediate as well as immature
DCs, after specific labeling with anti–DC-SIGN mAb and 10-nm gold parti-
cles. It should be noted that the specimens were not sectioned, thus, mak-
ing the whole cell surface available for gold labeling and subsequent TEM
analysis. DCs were adhered onto fibronectin-coated formvar film, fixed,
and labeled as described in Materials and methods, and finally analyzed by
TEM. Given the high capacity of both intermediate and immature DCs to
widely spread on the substrate, very large membrane areas (often up to 60–
70% of the whole visible plasma membrane) were available for gold parti-
cles analysis, ensuring that the areas used for quantitation were truly rep-
resentative. One representative overview of DCs on fibronectin-coated
formvar is shown. Bar, 6 m. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200306112/DC1.
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